NCT07667309 The Effects of Stellate Ganglion Block Sleep in U.S. Active Duty Service Members and Veterans Receiving Prolonged Exposure Therapy for PTSD
| NCT ID | NCT07667309 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Texas Health Science Center at San Antonio |
| Condition | Post Traumatic Stress Disorder PTSD |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-06-15 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2026-06-15 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Participants in this study will have already been enrolled in another research study: Combining Stellate Ganglion Block with Prolonged Exposure for PTSD, NCT05889741. The investigators are using a Sleep Profiler, EEG headband to monitor a participants brainwaves while they sleep to see what effects the Stellate Ganglion Block injection has on their sleep. Participants will wear the headband for 3 nights before the injection and then 3 nights after the injection. Participants will also complete self-report questionnaires regarding their sleep prior to the injection and following the injection. Approximately 40 participants will be included in this study. This study is a nested observational study whereby participants in the parent study who elect to participate will have their sleep assessed using the EEG headband device and self-reported sleep measures performed.
Eligibility Criteria
Inclusion Criteria: 1. Ability to provide informed consent and follow study-related instructions. 2. Be randomized into the study titled "Combining Stellate Ganglion Block with Prolonged Exposure for PTSD: A Randomized Clinical Trial." NCT05889741 3. Indicates willingness to wear the Sleep Profiler sleep monitor and to complete self-report assessments. Exclusion Criteria: 1\. Pre-existing skin or soft tissue condition that precludes the ability to wear the Sleep Profiler headband.
Contact & Investigator
Kristi E Pruiksma, PhD, DBSM
PRINCIPAL INVESTIGATOR
The University of Texas Health Science Center at San Antonio
Frequently Asked Questions
Who can join the NCT07667309 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Post Traumatic Stress Disorder PTSD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07667309 currently recruiting?
Yes, NCT07667309 is actively recruiting participants. Contact the research team at pruiksma@uthscsa.edu for enrollment information.
Where is the NCT07667309 trial being conducted?
This trial is being conducted at Killeen, United States, San Antonio, United States.
Who is sponsoring the NCT07667309 clinical trial?
NCT07667309 is sponsored by The University of Texas Health Science Center at San Antonio. The principal investigator is Kristi E Pruiksma, PhD, DBSM at The University of Texas Health Science Center at San Antonio. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.